SynthesisAdvances in therapy2025

Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis.

Jing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.